A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Child and Adolescent Psychopharmacology"
DOI: 10.1089/cap.2019.0176
Abstract: Objective: To evaluate the efficacy and long-term safety of vilazodone in children and adolescent outpatients with major depressive disorder (MDD). Methods: Children and adolescents aged 7–17 years of age with MDD were randomized 2:2:1 to… read more here.
Keywords: week; depressive disorder; major depressive; placebo ... See more keywords